Zydus Cadila gets final approval from USFDA for Clobetasol Propionate Lotion

26 Sep 2019 Evaluate

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Clobetasol Propionate Lotion, (US RLD - Clobex Lotion), 0.05%. This medication is used to treat a variety of skin conditions like eczema, psoriasis, dermatitis, allergies and rash. Clobetasol reduces the swelling, itching and redness that can occur in these types of conditions. It will be manufactured at the group's Topical manufacturing facility at Ahmedabad.

The group now has 272 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

993.25 10.20 (1.04%)
13-May-2024 14:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1518.95
Dr. Reddys Lab 5903.90
Cipla 1417.50
Zydus Lifesciences 993.25
Lupin 1661.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.